| MR编号 | IE/V/0778/003 |
|---|
| 药品名称 | Clavusan 500 mg + 125 mg tablets for dogs |
|---|
| 活性成分 | - amoxicillin trihydrate 500.0 mg
- clavulanic acid 125.0 mg
|
|---|
| 剂型 | Tablet |
|---|
| 上市许可持有人 | Alfasan Nederland B.V, Kuipersweg 9, 3449 JA Woerden, Netherlands |
|---|
| 参考成员国 - 产品名称 | Ireland (IE) |
|---|
| 互认成员国 - 产品名称 | - Cyprus (CY)
- Netherlands (NL)
- Czechia (CZ)
- Austria (AT)
- Romania (RO)
- Spain (ES)
- Slovakia (SK)
- Portugal (PT)
- Slovenia (SI)
- Italy (IT)
- Croatia (HR)
- Greece (GR)
- Poland (PL)
- Latvia (LV)
- Lithuania (LT)
- Denmark (DK)
- Luxembourg (LU)
- Estonia (EE)
- Iceland (IS)
- France (FR)
- Hungary (HU)
- Germany (DE)
- Sweden (SE)
- Norway (NO)
- Bulgaria (BG)
- Belgium (BE)
Clavusan 500 mg + 125 mg - Finland (FI)
- United Kingdom (Northern Ireland) (XI)
|
|---|
| 许可日期 | 2023/02/08 |
|---|
| 最近更新日期 | 2024/07/10 |
|---|
| 药物ATC编码 | - QJ01CR02 amoxicillin and beta-lactamase inhibitor
| 申请类型 | - TypeLevel1：non-food
- TypeLevel2：Pharmaceutical
- TypeLevel3：Other Generic application Art 13.3 Dir 2001/82/EC
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|